Journal article icon

Journal article

Are there better methods of monitoring MRSA control than bacteraemia surveillance? An observational database study

Abstract:
Background: Despite a substantial burden of non-bacteraemic methicillin resistant Staphylococcus aureus (MRSA) disease, most MRSA surveillance schemes are based on bacteraemias. Using bacteraemia as an outcome, trends at hospital level are difficult to discern, due to random variation. We investigated rates of nosocomial bacteraemic and non-bacteraemic MRSA infection as surveillance outcomes. Methods and Findings: We used microbiology and patient administration system data from an Oxford hospital to estimate monthly rates of first nosocomial MRSA bacteraemia, and nosocomial MRSA isolation from blood/respiratory/sterile site specimens (‘‘sterile sites’’) or all clinical samples (screens excluded) in all patients admitted from the community for at least 2 days between April 1998 and June 2006. During this period there were 441 nosocomial MRSA bacteraemias, 1464 MRSA isolations from sterile sites, and 3450 isolations from clinical specimens (8% blood, 15% sterile site, 10% respiratory, 59% surface swabs, 8% urine) in over 2.6 million patient-days. The ratio of bacteraemias to sterile site and all clinical isolations was similar over this period (around 3 and 8-fold lower respectively), during which rates of nosocomial MRSA bacteraemia increased by 27% per year to July 2003 before decreasing by 18% per year thereafter (heterogeneity p < 0.001). Trends in sterile site and all clinical isolations were similar. Notably, a change in rate of all clinical MRSA isolations in December 2002 could first be detected with conventional statistical significance by August 2003 (p = 0.03). In contrast, when monitoring MRSA bacteraemia, identification of probable changes in trend took longer, first achieving p < 0.05 in July 2004. Conclusions: MRSA isolation from all sites of suspected infection, including bacteraemic and non-bacteraemic isolation, is a potential new surveillance method for MRSA control. It occurs about 8 times more frequently than bacteraemia, allowing robust statistical determination of changing rates over substantially shorter times or smaller areas than using bacteraemia as an outcome.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1371/journal.pone.0002378

Authors


More by this author
Institution:
"Oxford Radcliffe Hospitals NHS Trust, John Radcliffe Hospital, Oxford", "MRC Clinical Trials Unit, London"
Role:
Author
More by this author
Institution:
"Oxford Radcliffe Hospitals NHS Trust, John Radcliffe Hospital, Oxford"
Role:
Author
More by this author
Institution:
"Oxford Radcliffe Hospitals NHS Trust, John Radcliffe Hospital, Oxford"
Role:
Author
More by this author
Institution:
"Oxford Radcliffe Hospitals NHS Trust, John Radcliffe Hospital, Oxford"
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
RDM Clinical Laboratory Sciences
Role:
Author


Publisher:
Public Library of Science
Journal:
PLoS ONE More from this journal
Volume:
3
Issue:
6
Article number:
e2378
Publication date:
2008-06-01
Edition:
Publisher's version
DOI:
EISSN:
1932-6203


Language:
English
Keywords:
Subjects:
UUID:
uuid:423f7c5b-c60a-40c0-818d-a54eea44746f
Local pid:
ora:2397
Deposit date:
2008-10-20

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP